MA

Mohammad Aarif

Active Director Director DIN 08601967
DIN 08601967 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Mohammad Aarif

Data last updated:

Mohammad Aarif is a Director at Lexeme Pharmaceuticals Private Limited (since 2019). The company operates in Healthcare. Lexeme Pharmaceuticals Private Limited reported revenue of ₹1,010 (FY 2024).

DIN 08601967
Primary Designation Director
Industry Healthcare
First Appointment 22 Nov 2019
Oldest Company Age 6 yrs
Largest company Lexeme Pharmaceuticals Private Limited · ₹1,010 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Nov 20192019₹1,010 (FY 2024)Active

Board colleagues of Mohammad Aarif

NameDINCompanyDesignation
Mohammad Kasim08601983Lexeme Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lexeme Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohammad Aarif

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Aarif

Mohammad Aarif currently holds 1 directorship: Lexeme Pharmaceuticals Private Limited (Director, since 22 Nov 2019, revenue ₹1,010 (FY 2024)).

Mohammad Aarif was first appointed on 22 Nov 2019 as Director at Lexeme Pharmaceuticals Private Limited.

The current boards of Mohammad Aarif's companies include Mohammad Kasim (Lexeme Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available